Showing results (151-160 of 187) with videos related to
Sort By:
Pageof 19
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 24, 2024
Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A)Kozo Kataoka, Akira Ouchi, Yusuke Suwa, et al.Japanese Journal of Clinical Oncology|May 22, 2025
Protocol digest of a single-arm confirmatory trial for less intensive postoperative surveillance in low-risk colorectal cancer patients: JCOG1915 (less study)Yuta Sekino, Konosuke Moritani, Junki Mizusawa, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trialKohei Shitara, Atsuo Takashima, Kazumasa Fujitani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)Katsuko Kikuchi, Naoya Yamazaki, Keiko Nozawa, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2025
Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II/III colorectal cancer: An integrated analysis of three Phase III randomized controlled trials (JCOG2310AS2)Marie Hanaoka, Kozo Kataoka, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa, et al.European Journal of Cancer (Oxford, England : 1990)|November 23, 2024
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A)Hidekazu Hirano, Kozo Kataoka, Toshifumi Yamaguchi, et al.Cancer Medicine|August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit studySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.Journal of Cancer Research and Clinical Oncology|July 27, 2024
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational studyKoshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, et al.Pageof 19